News + Filings Transactions
|
Burstein Jennifer
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/13/2023 | Stoke Therapeutics, Inc. | STOK | Grant | Director Stock Option (Right to Buy) | 19.4k | $12.46 | $242.2k | | 06/13/2023 |
06/07/2022 | Stoke Therapeutics, Inc. | STOK | Grant | Director Stock Option (Right to Buy) | 21k | $12.96 | $272.2k | | 06/07/2022 |
06/08/2021 | Stoke Therapeutics, Inc. | STOK | Grant | Director Stock Option (Right to Buy) | 11.6k | $40.37 | $470.3k | | 06/08/2021 |
06/03/2020 | Stoke Therapeutics, Inc. | STOK | Grant | Director Stock Option (Right to Buy) | 14.8k | $26.53 | $392k | | 06/03/2020 |
09/10/2019 | Stoke Therapeutics, Inc. | STOK | Grant | Director Stock Option (Right to Buy) | 29.6k | $28.80 | $851.2k | | 09/10/2019 |
02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 17.5k | $11.35 | $198.6k | | 02/15/2019 |
02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 28k | $26.27 | $735.6k | | 02/15/2019 |
02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 28k | $31.69 | $887.3k | | 02/15/2019 |
02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 12k | $43.56 | $522.7k | | 02/15/2019 |
02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 40k | $84.88 | $3.4M | | 02/15/2019 |
02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 20k | $139.77 | $2.8M | | 02/15/2019 |
01/02/2019 | Loxo Oncology, Inc. | LOXO | Grant | Employee Stock Option (Right to Buy) | 20k | $139.77 | $2.8M | | 01/02/2018 |
12/11/2018 | Loxo Oncology, Inc. | LOXO | Exercise | Employee Stock Option (Right to Buy) | 1.2k | $11.35 | $14.2k | | 12/10/2018 |
12/11/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 200 | $135.69 | $27.1k | | 12/10/2018 |
12/11/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 587 | $136.98 | $80.4k | | 12/10/2018 |
12/11/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 263 | $137.88 | $36.3k | | 12/10/2018 |
12/11/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 100 | $139.36 | $13.9k | | 12/10/2018 |
12/11/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 100 | $140.48 | $14k | | 12/10/2018 |
12/10/2018 | Loxo Oncology, Inc. | LOXO | Exercise | Employee Stock Option (Right to Buy) | 1.2k | $11.35 | $14.2k | | 12/10/2018 |
12/10/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 100 | $130.79 | $13.1k | | 12/10/2018 |
12/10/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 400 | $132.44 | $53k | | 12/10/2018 |
12/10/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 100 | $133.34 | $13.3k | | 12/10/2018 |
12/10/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 550 | $134.71 | $74.1k | | 12/10/2018 |
12/10/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 100 | $136.04 | $13.6k | | 12/10/2018 |
11/27/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 200 | $137.89 | $27.6k | | 11/26/2018 |
11/27/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 200 | $143.84 | $28.8k | | 11/26/2018 |
11/27/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 100 | $147.09 | $14.7k | | 11/26/2018 |
11/27/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 100 | $148.20 | $14.8k | | 11/26/2018 |
11/27/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 100 | $151.55 | $15.2k | | 11/26/2018 |
11/27/2018 | Loxo Oncology, Inc. | LOXO | Exercise | Employee Stock Option (Right to Buy) | 1.2k | $11.35 | $14.2k | | 11/26/2018 |
11/27/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 350 | $138.95 | $48.6k | | 11/26/2018 |
11/27/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 200 | $140.94 | $28.2k | | 11/26/2018 |
11/26/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 100 | $156.04 | $15.6k | | 11/26/2018 |
11/26/2018 | Loxo Oncology, Inc. | LOXO | Exercise | Employee Stock Option (Right to Buy) | 1.2k | $11.35 | $14.2k | | 11/26/2018 |
11/26/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 300 | $155.13 | $46.5k | | 11/26/2018 |
|
|